نتایج جستجو برای: esomeprazole

تعداد نتایج: 700  

2014
Kenji Furuta Yukie Kohata Yasuhiro Fujiwara Mitsushige Sugimoto Takahiro Uotani Mihoko Yamade Shu Sahara Hitomi Ichikawa Takahisa Furuta Kenta Nio Ryuichi Iwakiri Masahiko Inamori Osamu Kawamura Motoyasu Kusano Mototsugu Kato Noriyuki Kawami Katsuhiko Iwakiri Toshihisa Takeuchi Kazuhide Higuchi Masahito Aimi Kohji Naora Kazuma Fujimoto Tetsuo Arakawa Yoshikazu Kinoshita

Comparisons between the acid inhibitory effects of rabeprazole and esomeprazole after single oral administration with standard doses have not been previously presented. We examined intra-gastric pH after oral administrations of these two proton pump inhibitors using 24-h pH monitoring. Fifty-four normal volunteers not infected by Helicobacter pylori were investigated. Using a cross-over design,...

2016
Li-Na Meng Shanshan Chen Jiande D Z Chen Hai-Feng Jin Bin Lu

Objective. To investigate effects and possible mechanisms of transcutaneous electrical acustimulation (TEA) performed by a wearable watch-size stimulator for refractory gastroesophageal reflux disease (RGERD). Methods. Twenty patients diagnosed as RGERD were enrolled in the study and randomly divided into four groups: esomeprazole group (Group A), esomeprazole combined with TEA group (Group B),...

2017
Enrica Balza Patrizia Castellani Paola Sanchez Moreno Patrizia Piccioli Iria Medraño-Fernandez Claudia Semino Anna Rubartelli

Neoplastic cells live in a stressful context and survive thanks to their ability to overcome stress. Thus, tumor cell responses to stress are potential therapeutic targets. We selected two such responses in melanoma and sarcoma cells: the xc- antioxidant system, that opposes oxidative stress, and surface v-ATPases that counteract the low pHi by extruding protons, and targeted them with the xc- ...

2010
Elizabet V Guimarães Paula VP Guerra Francisco J Penna

OBJECTIVE To review the literature on the treatment of gastroesophageal reflux disease (GERD) with emphasis on proton pump inhibitors (PPIs), particularly on delayed-release esomeprazole, and to identify properties and adverse effects of PPIs observed in the treatment of GERD in children and adolescents. SOURCES Electronic search of PubMed/Medline and Cochrane Collaboration databases, and of ...

2016
Takashi Ichida Fumihiko Kusano Yoshinori Sakai

Objectives: Gastric endoscopic submucosal dissection (ESD) is currently a standard procedure. ESD enables en-bloc resection of large lesions, while inducing larger artificial ulcers to a greater extent than conventional procedures. Several studies have reported that proton pump inhibitors (PPIs) prevent delayed bleeding and expedite the artificial ulcer healing process. Esomeprazole, an S-isome...

2010
Mohammad Niazi Debra G. Silberg Frank Miller Magnus Ruth Ann A. Holmberg

BACKGROUND Transient lower esophageal sphincter relaxations (TLESRs) have been identified as a primary cause of reflux events in patients with gastroesophageal reflux disease (GERD). GABA(B) receptor agonists such as lesogaberan (AZD3355) have been shown to inhibit TLESRs in healthy subjects and patients with GERD, and, therefore, offer a novel therapeutic add-on strategy to acid suppression fo...

2015
B. Ranganath Saleem Basha M. R. Jayapal Venkata Ramana

Esomeprazole is a new chromogenic reagent used for the determination of nickel (II) by direct spectrophotometric method. Esomeprazole forms a greenish yellow colouredcomplex with nickel (II) at pH 5. The method obeys Beer’s law over 0.139 – 1.394 μg mL -1 , Sandell’s sensitivity is 0.0029mg/cm 2 and molar absorptivity value (ε = 2.5 x 10 4 L mol -1 cm -1 ). The method is useful for determinatio...

Journal: :Alimentary pharmacology & therapeutics 2017
S Yi H Lee S B Jang H M Byun S H Yoon J-Y Cho I-J Jang K-S Yu

BACKGROUND YH4808, a K+ -competitive acid blocker, is under clinical development for the treatment of acid-related disorders, such as gastroesophageal reflux disease. AIMS To determine the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of YH4808, compared to placebo and esomeprazole. METHODS This double-blind, randomised, placebo- and active comparator (esomeprazole)...

2016
Ekkehard Bayerdörffer Marc-Andre Bigard Werner Weiss Fermín Mearin Luis Rodrigo Juan Enrique Dominguez Muñoz Hennie Grundling Tore Persson Lars-Erik Svedberg Nanna Keeling Stefan Eklund

BACKGROUND Most patients with gastroesophageal reflux disease experience symptomatic relapse after stopping acid-suppressive medication. The aim of this study was to compare willingness to continue treatment with esomeprazole on-demand versus continuous maintenance therapy for symptom control in patients with non-erosive reflux disease (NERD) after 6 months. METHODS This multicenter, open-lab...

2013
Katelyn W Sylvester Judy WM Cheng Mandeep R Mehra

Low dose aspirin therapy plays a fundamental role in both the primary and secondary prevention of cardiovascular events. Although the evidence using low dose aspirin for secondary prevention is well-established, the decision to use aspirin for primary prevention is based on an evaluation of the patient's risk of cardiovascular events compared to their risk of adverse events, such as bleeding. I...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید